Medicare Part D coverage · triamcinolone acetonide · RxCUI 1085644
triamcinolone acetonide 0.25 MG/ML Topical Cream
Per the CMS 2026 Part D formulary file, triamcinolone acetonide 0.25 MG/ML Topical Cream is covered by 5,052 Medicare Part D plans (100% of enrollable products), averaging Tier 1.6, with prior authorization required on 0% of covering formularies.
- 100%
- Plan coverage
- 5,052
- Plans covering
- T1.6
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for triamcinolone acetonide 0.25 MG/ML Topical Cream
Per the CMS 2026 Part D formulary file, triamcinolone acetonide 0.25 MG/ML Topical Cream (RxNorm concept RXCUI 1085644, generic name triamcinolone acetonide) appears on 328 distinct formulary files spanning 5,052 Medicare Part D plan offerings - 100% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 1.6.
Real-world access to triamcinolone acetonide 0.25 MG/ML Topical Cream depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 43.6% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 3,621,019 Part D beneficiaries filled triamcinolone acetonide 0.25 MG/ML Topical Cream in 2023, with total plan-and-beneficiary spending of $75,362,764 and an average per-beneficiary annual cost of $20.81. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry triamcinolone acetonide 0.25 MG/ML Topical Cream today.
Coverage Details
- Formularies covering
- 328
- Plans covering
- 5,052
- Coverage rate
- 100%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 43.6% of formularies
2023 Medicare Spending
- Beneficiaries
- 3,621,019
- Total spending
- $75,362,764
- Avg per beneficiary
- $20.81
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering triamcinolone acetonide 0.25 MG/ML Topical Cream
100 Medicare Advantage plans with Part D drug coverage include this drug.
Show the next 30 plans
Showing top 50 of 100 plans.
Frequently Asked Questions
Is triamcinolone acetonide 0.25 MG/ML Topical Cream covered by Medicare Part D?
Yes, triamcinolone acetonide 0.25 MG/ML Topical Cream is covered by 5,052 Medicare Part D plans (100% of all Part D formularies).
What tier is triamcinolone acetonide 0.25 MG/ML Topical Cream on Medicare Part D plans?
triamcinolone acetonide 0.25 MG/ML Topical Cream averages Tier 1.6 across Part D plans, ranging from Tier 1 to Tier 4.
Does triamcinolone acetonide 0.25 MG/ML Topical Cream require prior authorization?
0% of Part D formularies require prior authorization for triamcinolone acetonide 0.25 MG/ML Topical Cream. Step therapy: 0%. Quantity limits: 43.6%.
How much does Medicare spend on triamcinolone acetonide 0.25 MG/ML Topical Cream?
In 2023, total Medicare Part D spending on triamcinolone acetonide 0.25 MG/ML Topical Cream was $75,362,764, covering 3,621,019 beneficiaries. The average spend per beneficiary was $20.81.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
Similar prior-authorization rate
- metronidazole 10 MG/ML Topical Cream [Noritate] 0% PA
- 24 HR minocycline 40 MG Extended Release Oral Capsule [Emrosi] 0% PA
- buspirone hydrochloride 10 MG Oral Capsule [Bucapsol] 0% PA
- diflunisal 375 MG Oral Tablet [Dolobid] 0% PA
- hydrocortisone 1 MG/ML Oral Solution [Khindivi] 0% PA
- indomethacin 50 MG Rectal Suppository [Indocin] 0% PA